Keith Berelowitz, Richmond Pharmacology’s Director of Operations, wrote recently for Pharmaceutical Market Europe where he outlined methods that facilitate the successful recruitment and retention of patients - an essential element to delivering clinical studies on time.

The article focuses on the growing emphasis on improved patient engagement in trial development.  A key element in the success of clinical trials lies in the availability and subsequent experience of people volunteering to participate. It is therefore crucial that Richmond Pharmacology and trial sponsors understand patients’ lives and the factors that drive a patient’s decision to take part in a study. Examples are shared in the article about effective ways of doing this.

Richmond Pharmacology understands the importance of having a good relationship with patient volunteers. This can be achieved by removing potential barriers to trial participation, as well as ensuring that the volunteer is treated as an individual, rather than given a one-size-fits-all experience. Keith also highlights other criteria that sponsors should look for in a Contract Research Organisation (CRO) regarding patient retention – for example a guarantee that a trial will take place in a single centre research facility and that interaction with patients is never outsourced to a third party.

To read the full article, click here

Latest news

Clinical trials: how taking the pills can pay those bills.

April 20, 2022
The Guardian references Richmond Pharmacology in feature on reimbursement for clinical trial volunteers
Read more

Clinical trials and the patient perspective

May 6, 2022
Successful recruitment and retention of patients - an essential element to delivering clinical studies on time.
Read more


The Future of Healthcare - March 2022

13:30 – 16:00, 22nd March 2022
Discover the intricacies of assessing abnormal liver functions in clinical trial volunteers and gain insights from the latest drug development trials using RNAi therapeutics.
View event